​Furthermore, the Phe-MR analysis demonstrate that genetically predicted elevated PCSK9 levels were associated with an increased risk of cardiovascular diseases such as CHD and MI, as well as lipid metabolism disorders, including hyperlipidemia and hypercholesterolemia. Here, PCSK9 is linked to cardiovascular disorder.